Cormedix Announces FDA Acceptance for Priority Review of Supplemental NDA for Rezzayo® (Rezafungin) for Prophylaxis of Invasive Fungal Diseases
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| CORMEDIX, Inc. (NASDAQ: CRMD) | Delayed: 7.79 +0.22 (2.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.57 | 52 Week High | $4.54 | |||
| Open | $7.55 | 52 Week Low | $1.15 | |||
| Day High | $7.85 | P/E | N/A | |||
| Day Low | $7.51 | EPS | $-0.55 | |||
| Volume | 1,049,667 | |||||
